Role of [18 F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors

#3433

Introduction: Gastroenteropancreatic (GEP) neuroendocrine neoplasia (NET) is a heterogeneous disease. While 68-Ga PET is considered the gold standard in GEP-NETs, the role of [18F]FDG PET/CT is not well established, particularly in well-differentiated G1 NETs.

Aim(s): To evaluate the role of [18F]FDG PET/CT in well-differentiated G1 GEP-NETs.

Materials and methods: This is a retrospective study including patients with well-differentiated G1 GEP-NETs who underwent [18F]FDG PET/CT evaluation. Progression-free survival (PFS) was assessed by Kaplan–Meier curve analysis.

Conference:

Presenting Author: Magi L

Authors: Magi L, Prosperi D, Lamberti G, Marasco M, Ambrosini V,

Keywords: Neuroendocrine tumor, disease aggressiveness, prognosis, management, PET,